BioTelemetry Inc (BEAT)

28.60
NASDAQ : Health Care
Prev Close 28.60
Day Low/High 0.00 / 0.00
52 Wk Low/High 10.96 / 28.95
Avg Volume 327.40K
Exchange NASDAQ
Shares Outstanding 28.37M
Market Cap 797.22M
EPS 1.90
P/E Ratio 16.06
Div & Yield N.A. (N.A)

Latest News

BioTelemetry Reaches Analyst Target Price

BioTelemetry Reaches Analyst Target Price

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $25.00, changing hands for $25.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Sprint & BioTelemetry, Inc. Receive A 2017 IoT Evolution Business Impact Award

Sprint & BioTelemetry, Inc. Receive A 2017 IoT Evolution Business Impact Award

Award Recognizes Businesses that Deployed Successful IoT Solutions

BioTelemetry, Inc. Announces Acquisition Of Telcare's Remote Diabetes Management Platform

BioTelemetry, Inc. Announces Acquisition Of Telcare's Remote Diabetes Management Platform

Extends reach into rapidly expanding digital population health management market

Commit To Purchase BioTelemetry At $15, Earn 16.5% Annualized Using Options

Commit To Purchase BioTelemetry At $15, Earn 16.5% Annualized Using Options

Investors eyeing a purchase of BioTelemetry Inc stock, but cautious about paying the going market price of $16.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $15 strike, which has a bid at the time of this writing of $1.30.

BioTelemetry Breaks Below 200-Day Moving Average - Notable for BEAT

BioTelemetry Breaks Below 200-Day Moving Average - Notable for BEAT

In trading on Thursday, shares of BioTelemetry Inc crossed below their 200 day moving average of $15.67, changing hands as low as $15.25 per share. BioTelemetry Inc shares are currently trading off about 16.4% on the day.

BioTelemetry, Inc. Reports Third Quarter 2016 Financial Results

BioTelemetry, Inc. Reports Third Quarter 2016 Financial Results

Company Continues to Achieve Record Results

Buyers Get Picky About Bargains

Buyers Get Picky About Bargains

When stocks are pulling back then there are harder choices to make.

Shark Bites: Two Big Movers

Shark Bites: Two Big Movers

'If there are worries about the market topping out it isn't evident in [today's] price action.'

Shark Bites: Two Big Movers

Shark Bites: Two Big Movers

'If there are worries about the market topping out it isn't evident in [today's] price action.'

Ignore Market Jitters, Let Price Action Be the Guide

Ignore Market Jitters, Let Price Action Be the Guide

Equities are holding up well, despite concerns that good economic news increases the chances of a rate hike.

Shark Bites: Putting Cash to Work Isn't Easy

I may have to use an index play to get more money to work.

Shark Bites: No Market for Old Stock Pickers

Individual stock picks are much more difficult.

BioTelemetry, Vonage and TPI Composites Have Dipped

BioTelemetry, Vonage and TPI Composites Have Dipped

Ideally I'd like to buy a negative response to Janet Yellen tomorrow.

Stocks Look Lackluster as Markets Await Yellen

Stocks Look Lackluster as Markets Await Yellen

Cautious traders aren't doing much dip-buying.

BioTelemetry, Inc. Agrees To License Proprietary Technology To Bloom Technologies, Inc. For Use In Prenatal Market

BioTelemetry, Inc. Agrees To License Proprietary Technology To Bloom Technologies, Inc. For Use In Prenatal Market

Company seeks to expand capabilities into additional markets

Commit To Purchase BioTelemetry At $17, Earn 10% Annualized Using Options

Commit To Purchase BioTelemetry At $17, Earn 10% Annualized Using Options

Investors eyeing a purchase of BioTelemetry Inc stock, but cautious about paying the going market price of $21.03/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $17 strike, which has a bid at the time of this writing of 90 cents.

Buyers Are Finding Support Despite Negative Breadth

Buyers Are Finding Support Despite Negative Breadth

There is still some good speculative action out there.

BioTelemetry (BEAT) Is Today's Strong On High Volume Stock

BioTelemetry (BEAT) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified BioTelemetry (BEAT) as a strong on high relative volume candidate

BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results

BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results

Company Announces Record Performance and Increases Guidance

In the Red, and Breadth Is Steadily Slipping

In the Red, and Breadth Is Steadily Slipping

There is hesitancy to chase, especially with the FOMC rate decision this afternoon.

9-Day Churn Favors Upside Resolution

9-Day Churn Favors Upside Resolution

Tomorrow's FOMC decision is a convenient catalyst for a move.

BioTelemetry, Inc. Announces FDA Approval Of Its Next Generation Device, The MCOT™ Patch

BioTelemetry, Inc. Announces FDA Approval Of Its Next Generation Device, The MCOT™ Patch

Company provides best in class arrhythmia detection in a patch form factor

Market Momentum Is on the Move

Market Momentum Is on the Move

There are still a lot of bulls with a lot of cash.

What Will Trigger the Inevitable Pullback?

What Will Trigger the Inevitable Pullback?

Technical and macro negatives just don’t seem to matter.